Clinical trial
Randomized Study of the Effect of Initial Ropivacaine Dosage During Continuous Popliteal Nerve Blocks on Rebound Pain in Foot and Ankle Surgery
NCT04872322 is registered in ClinicalTrials.gov with Rothman Institute Orthopaedics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Study of the Effect of Initial Ropivacaine Dosage During Continuous Popliteal Nerve Blocks on Rebound Pain in Foot and Ankle Surgery
- Lead sponsor
- Rothman Institute Orthopaedics
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- August 31, 2017
- Completion date
- December 31, 2021
- Enrollment
- 128 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ankle surgery, foot surgery, popliteal nerve block